
3.34 Delayed Data As of Oct 03 | ![]() Today’s Change | 2.41 Today|||52-Week Range 4.65 | -13.92% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $802.9M |
ADMA Biologics, Inc. 465 State Route 17 South Ramsey New Jersey 07446 |
Adam S. Grossman | President, Chief Executive Officer & Director |
Atkinson Vernon | Operations Director |
Brian Lenz | Chief Financial Officer & Executive Vice President |
Kaitlin Kestenberg | Vice President-Compliance & Clinical Operations |
Lucy DeMario | Senior Director-Scientific & Data Analysis |